Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Morgan Stanley US Advantage Fund Class I - Accumulation (GBP)

Sell:2,618.33p Buy:2,618.33p Change: 57.86p (2.16%)
Prices as at 5 March 2021
Sell:2,618.33p
Buy:2,618.33p
Change: 57.86p (2.16%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 5 March 2021
Sell:2,618.33p
Buy:2,618.33p
Change: 57.86p (2.16%)
Prices as at 5 March 2021
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Our view on this Fund

This fund does not feature on the Wealth Shortlist of funds our analysts believe have the potential to outperform their peers over the long term. This is not a recommendation to sell; however, if you are thinking of adding to your investments, we believe the Wealth Shortlist is a good place to start. View funds on the Wealth Shortlist »

Our view on the sector

UK investors need little introduction to America. It's the world's biggest stock market and is home to world-leading companies in almost every industry there is, from media and film, through to manufacturing and transportation. We think most diversified portfolios should have some exposure to the US market. But it's one of the most heavily researched in the world so share prices of well-known companies can react quickly to new information. We think this can make it more difficult for fund managers to find opportunities missed by others and to consistently perform better than the broader market over the long term. Many funds investing in the US aim to grow the value of your original investment, rather than pay a high level of income. Some focus on the largest companies in the market. Others look for opportunities amongst small and medium-sized companies, which may offer greater growth potential, but are higher risk.

Performance Analysis

Performance analysis for this fund is not available.

Investment Philosophy

Investment philosophy for this fund is not available.

Process and Portfolio Construction

Process and portfolio construction for this fund are not available.

question mark Manager Track Record Based on HL Quantitative Research

This information is currently unavailable.

Fund Track Record

05/03/16 to 05/03/17 05/03/17 to 05/03/18 05/03/18 to 05/03/19 05/03/19 to 05/03/20 05/03/20 to 05/03/21
Annual return n/a 14.64% 14.08% 15.13% 51.00%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

Information about the fund

Fund manager biography

Manager Name: Armistead Nash
Manager start date: 15 September 2016
Manager located in: New York

Armistead Nash is an investor for Counterpoint Global. He joined Morgan Stanley in 2002 and has 19 years of investment experience. Armistead joined the team in 2004 as an investor. Previously, he was a member of the U.S. Research Group, working closely with Counterpoint Global. Prior to joining the firm, Armistead was an associate in investment product development at BlackRock Financial Management. Previously, he was a research analyst in high-yield research at KEA Capital. Armistead received a B.A. in history from the University of Virginia and an M.B.A. from the University of Virginia's Darden School of Business Administration.

Manager Name: David Cohen
Manager start date: 15 September 2016
Manager located in: New York

Dave Cohen is an investor for Counterpoint Global. He joined Morgan Stanley in 1993 and has 31 years of investment experience. Dave joined the team as an investor in 1999. Prior to joining the firm, Dave was a senior fund accountant at Alliance Capital. Previously, he was a fund accountant at Natwest and Wall Street Trust. Dave received a B.S. summa cum laude in management from Pace University.

Manager Name: Alex Norton
Manager start date: 15 September 2016
Manager located in: New York

Alexander Norton is an investor for Counterpoint Global. He joined Morgan Stanley in 2000 and has 24 years of investment experience. Prior to joining the firm, Alex was an associate in equity derivative sales and later an associate in equity research at Donaldson, Lufkin & Jenrette. Previously, he was a bond broker with Cantor Fitzgerald. Alex received a B.A. in history from the University of Pennsylvania and an M.B.A. in finance from Columbia Business School.

Manager Name: Dennis Lynch
Manager start date: 15 September 2016
Manager located in: New York

Dennis Lynch is the Head of Counterpoint Global at Morgan Stanley Investment Management. He joined Morgan Stanley in 1998 and has 25 years of investment experience. Prior to joining the firm, he worked as a sell-side analyst for J.P. Morgan Securities. Dennis received a B.A. in political science from Hamilton College and an M.B.A. with honors in finance from Columbia University.

Manager Name: Sandeep Chainani
Manager start date: 15 September 2016
Manager located in: New York

Sam Chainani is an investor for Counterpoint Global. He joined Morgan Stanley in 1996 and has 23 years of investment experience. Sam joined the team as an investor in 2000. Previously, he was a strategy specialist for our Inception and Discovery strategies. Sam received a B.S. in management with a concentration in finance from Binghamton University. He holds the Chartered Financial Analyst designation.

Manager Name: Jason Yeung
Manager start date: 15 September 2016
Manager located in: New York

Jason Yeung is an investor for Counterpoint Global. He joined Morgan Stanley in 2002 and has 22 years of investment experience. Jason joined the team in 2004 as an investor. Previously, he was a member of the U.S. Research Group, working closely with Counterpoint Global. Prior to joining the firm, Jason was a senior research analyst at Ramius Capital Group. Previously, he was an equity research associate at Deutsche Bank. Jason received a B.A., Phi Beta Kappa, in international relations from Johns Hopkins University and an M. Phil. in international relations from the University of Cambridge. He holds the Chartered Financial Analyst designation.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Benchmark data provided subject to this disclaimer.
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account